-
Regulus Therapeutics (NASDAQ:RGLS) Given "Buy" Rating at Canaccord Genuity Group
来源: Buzz FX / 18 3月 2025 11:56:16 America/New_York
Regulus Therapeutics (NASDAQ:RGLS) Given "Buy" Rating at Canaccord Genuity Group Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Regulus Therapeutics ( NASDAQ:RGLS - Get Free Report ) 's stock had its "buy" r
Read more...